Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Search News Archive

Pipeline Monitor
Janssen seeks Invokana expansion
FDA priority for risk reduction in kidney disease and CVD.
Top of the Hill
Hunt return sparks mixed response
Not everyone might be happy to see minister back in health.
Approvals Action
Janssen, Pfizer drugs copied
Competition added in cancer and pneumonia.